Clinical trials
Enrolling by invitation Phase 2/3 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pennsylvania | 2 |
| Vanderbilt University Medical Center | 2 |
| Ascendis Pharma Growth Disorders A/S | 1 |
| Cytokinetics | 1 |
| Denali Therapeutics Inc. | 1 |
| Disc Medicine, Inc | 1 |
| Foundation for Orthopaedic Research and Education | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Pharvaris Netherlands B.V. | 1 |
| QED Therapeutics, a BridgeBio company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcoholism | 2 |
| Dwarfism | 2 |
| Postoperative Pain | 2 |
| Achondroplasia | 1 |
| Angioedemas, Hereditary | 1 |
| Autism Spectrum Disorder | 1 |
| Back Pain | 1 |
| Bone Diseases | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
| Gender Dysphoria | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.